Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Multiple Sclerosis

  Free Subscription


03.10.2022

1 BMC Neurol
1 J Neuroimmunol
2 J Neurol
3 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
1 J Neurosci Res
6 Mult Scler
1 Neurol Clin Pract
1 Proc Natl Acad Sci U S A
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. GAVIRIA-CARRILLO M, Bueno-Florez SJ, Ortiz-Salas PA
    Assessment of sexual dysfunction in patients with multiple sclerosis: a perspective from neurologist.
    BMC Neurol. 2022;22:372.
    PubMed         Abstract available


    J Neuroimmunol

  2. MAGALASHVILI D, Mandel M, Dreyer-Alster S, Didikin M, et al
    Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
    J Neuroimmunol. 2022;372:577966.
    PubMed         Abstract available


    J Neurol

  3. MARGONI M, Pagani E, Preziosa P, Palombo M, et al
    In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis.
    J Neurol. 2022 Sep 24. pii: 10.1007/s00415-022-11386.
    PubMed         Abstract available

  4. PAGANI E, Storelli L, Pantano P, Petsas N, et al
    Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
    J Neurol. 2022 Sep 24. pii: 10.1007/s00415-022-11387.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  5. LANDI D, Bovis F, Grimaldi A, Annovazzi PO, et al
    Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2022 Sep 30. pii: jnnp-2022-329657.
    PubMed         Abstract available

  6. SHARMIN S, Malpas CB, Roos I, Diouf I, et al
    Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
    J Neurol Neurosurg Psychiatry. 2022 Sep 30. pii: jnnp-2022-329713.
    PubMed         Abstract available

  7. ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
    Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    J Neurol Neurosurg Psychiatry. 2022 Sep 28. pii: jnnp-2022-329854.
    PubMed         Abstract available


    J Neurol Sci

  8. GENTILI L, Capuano R, Gaetani L, Fiacca A, et al
    Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
    J Neurol Sci. 2022;442:120422.
    PubMed        


    J Neurosci Res

  9. BORDA M, Aquino JB, Mazzone GL
    Cell-based experimental strategies for myelin repair in multiple sclerosis.
    J Neurosci Res. 2022 Sep 26. doi: 10.1002/jnr.25129.
    PubMed         Abstract available


    Mult Scler

  10. BUHLER A, Wolbers M, Model F, Wang Q, et al
    Recurrent disability progression endpoints in multiple sclerosis clinical trials.
    Mult Scler. 2022 Sep 30:13524585221125382. doi: 10.1177/13524585221125382.
    PubMed         Abstract available

  11. ALEXANDER S, Braisher M, Tur C, Chataway J, et al
    The mSteps pilot study: Analysis of the distance walked using a novel smartphone application in multiple sclerosis.
    Mult Scler. 2022 Sep 30:13524585221124043. doi: 10.1177/13524585221124043.
    PubMed         Abstract available

  12. STRIK M, Eijlers AJ, Dekker I, Broeders TA, et al
    Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis.
    Mult Scler. 2022 Sep 30:13524585221125372. doi: 10.1177/13524585221125372.
    PubMed         Abstract available

  13. SARACENO L, Pirro F, Stigliano R, Agostoni EC, et al
    Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disorders.
    Mult Scler. 2022 Sep 28:13524585221125360. doi: 10.1177/13524585221125360.
    PubMed         Abstract available

  14. BRUIJSTENS AL, Stingl C, Guzel C, Stoop MP, et al
    Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood.
    Mult Scler. 2022 Sep 24:13524585221125369. doi: 10.1177/13524585221125369.
    PubMed         Abstract available

  15. POL-PATIL J, Glanz B, Safar L, Misasi E, et al
    MeTooMS: Sexual, physical, and emotional abuse experience among women with multiple sclerosis.
    Mult Scler. 2022 Sep 24:13524585221122169. doi: 10.1177/13524585221122169.
    PubMed         Abstract available


    Neurol Clin Pract

  16. WIJERATNE T, Jones EC, Grisold W, Carroll WM, et al
    Global Advocacy in Action: World Brain Day 2021 Dedicated to Stopping Multiple Sclerosis.
    Neurol Clin Pract. 2022;12:e1-e2.
    PubMed        


    Proc Natl Acad Sci U S A

  17. BEHRANGI N, Heinig L, Frintrop L, Santrau E, et al
    Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
    Proc Natl Acad Sci U S A. 2022;119:e2204509119.
    PubMed         Abstract available


    Rev Neurol

  18. SALDANA-INDA I, Aparicio-Pelaz D, Rodriguez-Montolio J, Sebastian-Torres B, et al
    [Usefulness of the kappa index in the diagnosis of multiple sclerosis and validation of reference values in the Community of Aragon].
    Rev Neurol. 2022;75:181-187.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: